NasdaqGS - Nasdaq Real Time Price USD

Enliven Therapeutics, Inc. (ELVN)

Compare
21.74
-2.41
(-9.98%)
At close: January 10 at 4:00:01 PM EST
21.74
0.00
(0.00%)
After hours: January 10 at 4:20:00 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
5AM PARTNERS VI, LLC Beneficial Owner of more than 10% of a Class of Security Sale Feb 14, 2024 --
BALLAL RAHUL D. Director Conversion of Exercise of derivative security Oct 8, 2024 22,341
COLLINS HELEN LOUISE Officer Conversion of Exercise of derivative security Oct 18, 2024 0
GUPTA RISHI Director and Beneficial Owner of more than 10% of a Class of Security Sale May 16, 2024 --
HEYMAN RICHARD A Director Sale Oct 18, 2024 --
HOHL BENJAMIN Chief Financial Officer Conversion of Exercise of derivative security Jan 3, 2025 13,000
KINTZ SAMUEL Chief Executive Officer Sale Oct 18, 2024 --
LYSSIKATOS JOSEPH P Officer Sale Oct 18, 2024 --
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security Sale May 16, 2024 --
PATEL ANISH Chief Operating Officer Sale Oct 18, 2024 --

Related Tickers